Therapeutic Group: Monoclonal Antibody Presentation Denosis 120: Each ml solution for injection contains Denosumab 70 mg. Description Denosumab is a human IgG2 monoclonal antibody with affinity and specificity for human RANKL (receptor activator of nuclear factor kappa-B ligand). Denosumab binds to RANKL, a transmembrane or soluble protein essential for the formation, function, and survival of […]